Dan Rujescu

4.4k total citations
18 papers, 919 citations indexed

About

Dan Rujescu is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Dan Rujescu has authored 18 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 7 papers in Psychiatry and Mental health and 5 papers in Molecular Biology. Recurrent topics in Dan Rujescu's work include Alzheimer's disease research and treatments (10 papers), Dementia and Cognitive Impairment Research (7 papers) and Diet and metabolism studies (3 papers). Dan Rujescu is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Dementia and Cognitive Impairment Research (7 papers) and Diet and metabolism studies (3 papers). Dan Rujescu collaborates with scholars based in Germany, France and United States. Dan Rujescu's co-authors include Harald Hampel, Katharina Büerger, Stefan Teipel, Verena Buschert, Oskar Hansson, Franck Lamberton, Silke Matura, Laurence O’Dwyer, David Prvulovic and Ina Giegling and has published in prestigious journals such as PLoS ONE, Biological Psychiatry and The Journal of Clinical Psychiatry.

In The Last Decade

Dan Rujescu

18 papers receiving 899 citations

Peers

Dan Rujescu
Dan Rujescu
Citations per year, relative to Dan Rujescu Dan Rujescu (= 1×) peers Patrizia A. Chiesa

Countries citing papers authored by Dan Rujescu

Since Specialization
Citations

This map shows the geographic impact of Dan Rujescu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Rujescu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Rujescu more than expected).

Fields of papers citing papers by Dan Rujescu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Rujescu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Rujescu. The network helps show where Dan Rujescu may publish in the future.

Co-authorship network of co-authors of Dan Rujescu

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Rujescu. A scholar is included among the top collaborators of Dan Rujescu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Rujescu. Dan Rujescu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Nabers, Andreas, Laura Perna, Julia Lange, et al.. (2018). Amyloid blood biomarker detects Alzheimer's disease. EMBO Molecular Medicine. 10(5). 147 indexed citations
2.
Shen, Yong, Qiying Sun, Hailan Yao, et al.. (2017). Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer’s Disease Dementia in Individuals With Mild Cognitive Impairment. Biological Psychiatry. 83(5). 447–455. 91 indexed citations
3.
Schulte, Eva C., Alexander Kurz, Panagiotis Alexopoulos, et al.. (2015). Excess of rare coding variants in PLD3 in late- but not early-onset Alzheimer’s disease. Human Genome Variation. 2(1). 14028–14028. 11 indexed citations
4.
Lista, Simone, Zaven S. Khachaturian, Dan Rujescu, et al.. (2015). Application of Systems Theory in Longitudinal Studies on the Origin and Progression of Alzheimer’s Disease. Methods in molecular biology. 1303. 49–67. 29 indexed citations
5.
Lautner, Ronald, Sebastian Palmqvist, Niklas Mattsson, et al.. (2014). Apolipoprotein E Genotype and the Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers for Alzheimer Disease. JAMA Psychiatry. 71(10). 1183–1183. 75 indexed citations
6.
Taverna, Myriam, Tobias Straub, Harald Hampel, Dan Rujescu, & Stefan F. Lichtenthaler. (2013). A New Sandwich Immunoassay for Detection of the α-Secretase Cleaved, Soluble Amyloid-β Protein Precursor in Cerebrospinal Fluid and Serum. Journal of Alzheimer s Disease. 37(4). 667–678. 10 indexed citations
7.
O’Dwyer, Laurence, Franck Lamberton, Silke Matura, et al.. (2012). Reduced Hippocampal Volume in Healthy Young ApoE4 Carriers: An MRI Study. PLoS ONE. 7(11). e48895–e48895. 127 indexed citations
8.
O’Dwyer, Laurence, Franck Lamberton, Silke Matura, et al.. (2012). White Matter Differences between Healthy Young ApoE4 Carriers and Non-Carriers Identified with Tractography and Support Vector Machines. PLoS ONE. 7(4). e36024–e36024. 21 indexed citations
9.
Buschert, Verena, Ina Giegling, Stefan Teipel, et al.. (2012). Long-Term Observation of a Multicomponent Cognitive Intervention in Mild Cognitive Impairment. The Journal of Clinical Psychiatry. 73(12). e1492–e1498. 48 indexed citations
10.
Prvulovic, David, Silke Matura, Laurence O’Dwyer, et al.. (2012). O4‐03‐05: APOE‐ε4 genotype affects brain function without apparent micro‐ and macrostructural changes in young adults: A multimodal fMRI, DTI and VBM study. Alzheimer s & Dementia. 8(4S_Part_17). 2 indexed citations
11.
Koppel, Jeremy, Fabien Campagne, Valérie Vingtdeux, et al.. (2011). CALHM1 P86L Polymorphism Modulates CSF Aβ Levels in Cognitively Healthy Individuals at Risk for Alzheimer’s Disease. Molecular Medicine. 17(9-10). 974–979. 19 indexed citations
12.
Büerger, Katharina, Stefan Teipel, Olga Uspenskaya, et al.. (2011). Antihypertensive Therapy Is Associated with Reduced Rate of Conversion to Alzheimer's Disease in Midregional Proatrial Natriuretic Peptide Stratified Subjects with Mild Cognitive Impairment. Biological Psychiatry. 70(2). 145–151. 22 indexed citations
13.
Buschert, Verena, Uwe Friese, Stefan Teipel, et al.. (2011). Effects of a Newly Developed Cognitive Intervention in Amnestic Mild Cognitive Impairment and mild Alzheimer's disease: A Pilot Study. Journal of Alzheimer s Disease. 25(4). 679–694. 124 indexed citations
14.
Rujescu, Dan. (2011). S.01.02 Metabolomics: how to better diagnose and understand drug response in schizophrenia. European Neuropsychopharmacology. 21. S185–S185. 1 indexed citations
15.
Zetzsche, Dirk Andreas, Dan Rujescu, John Hardy, & Harald Hampel. (2010). Advances and perspectives from genetic research: development of biological markers in Alzheimer’s disease. Expert Review of Molecular Diagnostics. 10(5). 667–690. 50 indexed citations
16.
Reif, Andreas, Christian Jacob, Dan Rujescu, et al.. (2009). Influence of Functional Variant of Neuronal Nitric Oxide Synthase on Impulsive Behaviors in Humans. Archives of General Psychiatry. 66(1). 41–41. 99 indexed citations
17.
Giegling, Ina, et al.. (2008). Systems Biology and Complex Neurobehavioral Traits. Pharmacopsychiatry. 41(S 01). S32–S36. 11 indexed citations
18.
Preuss, U. W., Dan Rujescu, Ina Giegling, et al.. (2003). Evaluation der deutschen Version der Barratt Impulsiveness Scale (BIS 5). Fortschritte der Neurologie · Psychiatrie. 71(10). 527–534. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026